Pretarsal application of botulinum toxin for treatment of blepharospasm.
AUTOR(ES)
Aramideh, M
RESUMO
The response to botulinum toxin type A was compared after two injection techniques in 45 patients with blepharospasm. Initially, patients were treated according to a triple injection technique; two injections into the upper eyelid and one injection into the lower eyelid. Subsequently, without altering the dose, the same patient group received two further injections into the pretarsal portion of the orbicularis oculi muscle of the upper lid. Triple injections were given in 227 treatments, of which 81% were successful. Mean duration of benefit was 8.5 weeks. Additional pretarsal injections were given in 183 treatment sessions. The number of successful treatments significantly increased, to 95% (P < 0.001), and the mean duration of benefit increased to 12.5 weeks (P < 0.001). Ptosis occurred significantly less often after pretarsal injections (P < 0.01). Patients with combined blepharospasm and involuntary levator palpebrae inhibition responded better to the pretarsal injection technique.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=486037Documentos Relacionados
- Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.
- Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.
- Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
- Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients.
- Botulinum toxin for the treatment of blepharospasm and strabismus.